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Oxidation of Myofibrillar Proteins
in Human Heart Failure
Marcella Canton, PHD,* Sara Menazza, MSC,* Freya L. Sheeran, PHD,†
Patrizia Polverino de Laureto, PHD,‡ Fabio Di Lisa, MD,* Salvatore Pepe, PHD†
Padova, Italy; and Melbourne, Australia
Objectives We investigated the incidence and contribution of the oxidation/nitrosylation of tropomyosin and actin to the
contractile impairment and cardiomyocyte injury occurring in human end-stage heart failure (HF) as compared
with nonfailing donor hearts.
Background Although there is growing evidence that augmented intracellular accumulation of reactive oxygen/nitrogen spe-
cies may play a key role in causing contractile dysfunction, there is a dearth of data regarding their contractile
protein targets in human HF.
Methods In left ventricular (LV) biopsies from explanted failing hearts (New York Heart Association functional class IV; HF
group) and nonfailing donor hearts (NF group), carbonylation of actin and tropomyosin, disulphide cross-bridge
(DCB) formation, and S-nitrosylation in tropomyosin were assessed, along with plasma troponin I and LV ejection
fraction (LVEF).
Results The LV biopsies from the HF group had 2.14  0.23-fold and 2.31  0.46-fold greater levels in actin and tropo-
myosin carbonylation, respectively, and 1.77  0.45-fold greater levels of high-molecular-weight complexes of
tropomyosin due to DCB formation, compared with the NF group. Tropomyosin also underwent S-nitrosylation
that was 1.3  0.15-fold higher in the HF group. Notably, actin and tropomyosin carbonylation was significantly
correlated with both loss of viability indicated by plasma troponin I and contractile impairment as shown by re-
duced LVEF.
Conclusions This study demonstrated that oxidative/nitrosylative changes of actin and tropomyosin are largely increased in
human failing hearts. Because these changes are inversely correlated to LVEF, actin and tropomyosin oxidation
are likely to contribute to the contractile impairment evident in end-stage HF. (J Am Coll Cardiol 2011;57:
300–9) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.058l
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ceart failure (HF) is a common clinical disorder character-
zed by complex pathophysiology with substantial morbidity
nd mortality. Increased production of reactive oxygen
pecies (ROS) has been suggested to contribute to HF (1–3)
ecause oxidative stress appears to be involved in cardiac
emodeling, mechanoenergetic uncoupling, and altered cal-
ium sensitivity (4–6). The key signaling role of ROS in
yocyte hypertrophy, apoptosis, and interstitial fibrosis has
een demonstrated in genetic models, such as the manganese
uperoxide dismutase knockout mice (7), and by pharmaco-
rom the *Department of Biomedical Sciences, University of Padova, Padova, Italy;
Department of Surgery, Monash University, Alfred Hospital and Heart Research
CN, Murdoch Children’s Research Institute, Melbourne, Australia; and the
CRIBI Biotechnology Centre, Padova, Italy. The study was supported by the
niversity of Padova (CPDA068417/06 PA to Dr. Canton), MIUR, CNR (to Dr. Di
isa), and the National Health & Medical Research Council of Australia (project
rants to Dr. Pepe and Dora Lush postgraduate scholarship to Dr. Sheeran). The
uthors have reported that they have no relationships to disclose.s
Manuscript received April 2, 2010; revised manuscript received June 10, 2010,
ccepted June 16, 2010.ogic studies in experimental animal models (8,9). Although
ormation of ROS can be directly measured in experimental
odels (10), oxidative stress can only be assessed by measuring
ipid peroxidation and DNA and protein oxidation in clinical
ettings. Nevertheless, the identity of individual myocardial
roteins and the nature of structural modifications arising from
heir reactivity with ROS have been investigated infrequently
n experimental models of HF, and virtually no data are
vailable in human HF.
See page 310
Actin and tropomyosin (Tm) have been shown to be
ajor targets of oxidation during ischemia-reperfusion of
he isolated rat heart (11). We previously demonstrated in
xperimental models of coronary microembolization that
he resultant contractile dysfunction was related to disulfide
ross-bridge (DCB) formation in Tm, at the level of its
ingle cysteinyl residue (12).
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301JACC Vol. 57, No. 3, 2011 Canton et al.
January 18, 2011:300–9 Tropomyosin and Actin Oxidation in Heart FailureThe present study was designed to extend these findings
o human HF, with specific aims to: 1) investigate the
ccurrence of myofibrillar protein (MP) oxidation in biop-
ies from explanted end-stage failing and nonfailing (NF)
onor hearts; 2) quantify the extent of these modifications;
nd 3) evaluate the correlation of these parameters with
arkers of myocardial viability and contractile impairment.
he results indicated a significant increase of: 1) actin and
m carbonylation; and 2) Tm DCB formation in left
entricular (LV) biopsies from the HF group compared
ith the NF group. Strikingly, MP oxidation correlated
ignificantly with both contractile impairment and loss of
yocardial viability. In addition, besides changes due to
OS, we found that Tm is modified by S-nitrosylation and
his modification occurs to a larger extent in failing hearts.
ethods
atient samples and clinical measures. The use of dis-
arded explanted failing heart tissue biopsies was approved
y the Alfred Hospital Human Ethics Committee for
iscarded Tissue Research. The NF donor hearts that were
xcluded from transplantation were approved for research by
onor family consent and the Victorian Organ Donation
ervice, Australian Red Cross. Biopsies were snap-frozen in
iquid nitrogen within approximately 3 h of aortic cross-
lamp for cardiac explantation. Plasma cardiac troponin I
cTnI) levels were measured within a few days prior to
xplantation using an automated chemiluminescent micro-
article immunoassay as per the assay manufacturer (Archi-
ect ci8200 Integrated System, Abbott Laboratories, Abbott
ark, Illinois). Ejection fraction was estimated by the
impson biplane method at echocardiography. Septal and
osterior wall thickness, LV end-diastolic diameter, and LV
nd-systolic diameter were measured in the parasternal
ong-axis view, whereas left atrial area and right atrial area
ere measured in the apical 4-chamber view at end-systole
13). When multiple measures per patient were available for
TnI or echocardiography, the last recorded values (closest
o cardiac explantation) were used.
rotein carbonylation. Total myocardial protein carbony-
ation was measured using the Oxyblot protein oxidation
etection kit (Chemicon, Temecula, California) according to
he manufacturer’s protocol. Briefly, carbonyl groups were
erivatized by reaction with 2,4-dinitrophenylhydrazine for 15
in. Dinitrophenyl-derivatized proteins were resolved by so-
ium dodecylsulphate–polyacrylamide gel electrophoresis
SDS-PAGE) and transferred to a polyvinylidene fluoride
embrane. Membranes were incubated overnight with anti-
initrophenyl primary antibodies and then with goat anti-
abbit/horseradish peroxidase antibodies. Signals were visual-
zed by chemiluminescence detection using a Kodak X-Omat
lm processor. Carbonylated actin and Tm were quantified by
ormalizing the bands of actin and Tm in the Oxyblot for the
orresponding band stained with EZBlue-Coomassie brilliant
lue G-250 (Sigma-Aldrich, St. Louis, Missouri) using the puantity One software (Bio-Rad,
ercules, California). The mem-
ranes were stripped with Restore
estern blot stripping buffer
Thermo Scientific, Waltham,
assachusetts) and reprobed with
nti-alpha-sarcomeric actin 5C5
lone and anti-Tm CH1 clone
ntibodies (Sigma-Aldrich).
rotein extraction and immuno-
lectrophoresis. Tropomyosin
xidation was assessed in a blinded
anner as reported (12). Briefly,
eart biopsies were homogenized
n ice-cold phosphate-buffered sa-
ine (pH 7.2) containing 5 mM
DTA. Just before use, the solution was stirred under vacuum
nd bubbled with argon to reduce the oxygen tension. The
omogenate was centrifuged, and the resulting pellet was
esuspended in sample buffer containing 1% beta-
ercaptoethanol. This conventional procedure, referred to as
reducing condition,” was compared with the “nonreducing
onditions” obtained by using the same sample buffer devoid of
eta-mercaptoethanol. To avoid artifacts owing to oxidation of
hiol groups in vitro, nonreducing conditions were performed
n the presence of 1 mM N-ethylmaleimide. Protein samples
ere subjected to SDS-PAGE and then transferred overnight
o nitrocellulose membranes (Bio-Rad) at 150 mA. The
embranes were incubated with monoclonal anti-Tm anti-
ody CH1 clone, as described (12). Tropomyosin oxidation
as quantified by assessing the density of high-molecular-
eight complexes that appeared only under nonreducing con-
itions. Densitometry was performed on scanned immuno-
lots by using ImageJ software (National Institutes of Health,
ethesda, Maryland). The density of immunoblot bands was
ormalized to Ponceau red staining to take differences in
ample loading into account. An identical procedure of com-
arison between reducing and nonreducing conditions was
sed to investigate the oxidation of other MPs. To this aim,
he following monoclonal antibodies were used: 1) anti–alpha-
arcomeric actin 5C5 clone (Sigma-Aldrich); 2) anti-desmin
E-B-5 clone (Oncogene Science, Cambridge, Massachu-
etts); 3) anti–myosin light chain MY-21 clone (Sigma-
ldrich); 4) anti-TnI (Mab 8I-7, Spectral Diagnostic, To-
onto, Ontario, Canada); and 5) anti-TnC (Biodesign, Saco,
aine).
etection of S-nitrosylation in purified Tm. Rat cardiac
m prepared as described (14) was purified by high-
ressure liquid chromatography (HPLC) Agilent 1100
eries (Agilent Technologies, Santa Clara, California) using
Jupiter-C18 column (Phenomenex, Torrance, California)
nd incubated with 0.1 or 0.5 mM S-nitrosoglutathione
Sigma-Aldrich) for 1 h at room temperature in the dark.
he occurrence of S-nitrosylated Tm was assessed by means
f the biotin-switch assay (15,16) using the S-nitrosylation
Abbreviations
and Acronyms
cTnI  cardiac troponin I
DCB  disulphide
cross-bridge
HF  heart failure
LV  left ventricular
LVEF  left ventricular
ejection fraction
MP  myofibrillar protein
NF  nonfailing
ROS  reactive oxygen
species
Tm  tropomyosinrotein detection kit (Cayman Chemical, Ann Arbor,
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Tropomyosin and Actin Oxidation in Heart Failure January 18, 2011:300–9ichigan). This method is aimed at converting nitrosylated
ysteines into biotinylated cysteines. Briefly, free thiols of
roteins were blocked with the thiol-specific agent methyl-
ethanethiosulfonate. Then S-nitrosothiols were selectively
educed by ascorbate to form thiols, which were reacted
ith N-[6-(biotinamido)hexyl]-3=-(2=-pyridyldithio)-
ropionamide, a sulfhydryl-specific biotinylating reagent.
he addition of ascorbate is essential to provide this method
ith specificity. In fact, ascorbate generates a thiol from
-nitrosothiols but not from alternatively S-oxidized thiols
e.g., disulfides, sulfenic acids) (16). Both preparative pro-
edures were performed in the dark to prevent light-induced
leavage of S-nitrosothiols. Before immunoblot analysis, the
iotinylated/S-nitrosylated Tm was precipitated with avidin
garose beads and eluted with 1 mM dithiothreitol. Finally,
he resuspended Tm was subjected to: 1) anti-Tm immu-
oblotting; and 2) mass spectrometric analysis.
rotein identification by mass spectrometric analysis.
ropomyosin was subjected to SDS-PAGE and stained by
oomassie Brilliant Blue G-250 (Bio-Rad). The identity of
he protein was determined by mass spectrometry of the
rotein material purified by reverse-phase HPLC. Mass deter-
ination was obtained with an electrospray-ionization mass
pectrometer with a Q-Tof analyzer micro from Micromass
Manchester, United Kingdom). The measurements were
onducted at a capillary voltage of 2.5 to 3 kV and a cone
oltage of 30 to 35 V. The molecular masses of protein samples
ere estimated using Mass-Lynx software 4.1 (Micromass).
etection of protein S-nitrosylation in LV biopsies. The
rocedure used for the purified protein was slightly modified
o assess protein S-nitrosylation in human biopsies. Briefly,
amples were homogenized in ice-cold phosphate-buffered
aline (pH 7.2) containing 1 mM EDTA and 0.1 mM
eocuproine and centrifuged at 12,000 g for 10 min. The
esulting pellet underwent the biotin-switch assay according
o the S-nitrosylation detection kit. Finally, the biotinylated/
-nitrosylated samples were immunoprecipitated with
nti-Tm antibodies and analyzed by nonreducing SDS-
AGE, followed by immunoblotting with anti-biotin or
nti-Tm antibodies. Densitometry was performed on scanned
mmunoblots using ImageJ software (National Institutes of
ealth).
tatistics. Results are presented as mean  SD. Contrasts
etween NF and HF groups were performed via 2-tailed
npaired Student t test and Fisher exact tests when indicated.
ultiple linear regression analyses (SPSS version 17.0, SPSS,
nc., Chicago, Illinois) were performed to determine correla-
ion between oxidative measures and sample parameters such
s LV ejection fraction (LVEF) and prior cTnI release. For all
ests, p  0.05 was considered significant.
esults
he oxidative modification of MPs was assessed in heart
amples from patients with HF undergoing heart transplan-
ation (New York Heart Association functional class IV) as mompared with NF donors. Initially we measured the most
idely studied protein modification induced by ROS, namely
arbonylation. This alteration, resulting from severe oxidative
tress, was assessed by means of Oxyblot. Figure 1A shows
hat several proteins were carbonylated. We measured the
egree of oxidation of 2 bands, whose migration corre-
ponded to that of Tm and actin. Their identity was
onfirmed by immunoblot (Fig. 1A) and by 2-dimensional
xyblots (Online Fig. 1). Figure 1B shows that Tm and
ctin carbonylation was significantly higher in patients with
F than in NF donors. The total amount of actin and
ropomyosin was not different between failing and nonfail-
ng hearts (data not shown).
In the HF group, LVEF was significantly lower (Table 1)
24.2%  8.7% vs. 64.2%  12.9% in the NF group; p 
.0001). Age, sex, and cardiac ischemic time (from aortic
ross-clamp to freezing of biopsy) did not differ significantly
etween the NF and HF groups and had no detectable
mpact on any of the molecular analyses as determined by
ultiple linear regression analyses (coefficient, standard error,
nd p value, respectively: age 0.00377, 0.0023, 0.108; sex
0.129, 0.0852, 0.136; cardiac ischemia 0.0005, 0.00048,
.259).
Notably, the degree of Tm and actin carbonylation
ignificantly correlated with the contractile impairment, as
hown by a reduction of LVEF (Fig. 2A). The within-group
orrelation between LVEF and Tm oxidation in HF was
ignificant (NF y0.0365x 3.7962, r2 0.27, p 0.02;
F y  0.0747x  5.6563, r2  0.14, p  0.04). The
ithin-group correlation between LVEF and actin oxidation
n HF was also significant (NF y  0.032x  4.5437, r2 
.17, p  0.04; HF y  0.1068x  8.302, r2  0.39, p 
.0004). This is the first demonstration that HF is related to
xidative changes of specific MPs in humans.
Oxidative stress is well established in causing loss of
ellular viability, and cTnI release into plasma is a useful
linical diagnostic marker of myocardial cell injury. Plasma
TnI levels were significantly higher in the HF than in the
F group (4.2  2.3 g/l vs. 1.3  2.1 g/l; p  0.0001)
Table 1), and importantly, correlated with the extent of Tm
nd actin carbonylation (Fig. 2B). Significant within-group
orrelations were evident between cTnI and Tm oxidation
n HF (NF y  0.3718x  1.352, r2  0.07, p  0.28; HF
 0.2755x  2.39, r2  0.12, p  0.048) and between
TnI and Actin oxidation in HF (NF y  0.5816x  2.19,
2  0.14, p  0.11; HF y  0.3156x  4.06, r2  0.22,
 0.012).
Based upon these findings that provided evidence of the
orrelation between contractile impairment and MP car-
onylation in failing myocardium, we characterized the
xidative modifications occurring at the level of cysteine
esidues. In particular, we analyzed Tm oxidation because
e previously demonstrated that this protein modification is
inearly related to contractile impairment in experimental
odels (12).
i
f
m
l
t
i
u
o
v
o
303JACC Vol. 57, No. 3, 2011 Canton et al.
January 18, 2011:300–9 Tropomyosin and Actin Oxidation in Heart FailureAs shown by the typical example in Figure 3A, anti-Tm
mmunoblots displayed additional bands in samples obtained
rom the HF group. Because the appearance of high-
olecular-weight bands could also result from other cross-
inking processes, such as the activation of transglutaminase,
he attribution to DCB formation was determined by compar-
Figure 1 Tm and Actin Carbonylation Is Increased in HF
(A) Total myocardial protein extracts from left ventricular biopsies of heart failure
derivatization to detect protein carbonylation and then analyzed by immunoblot pro
and tropomyosin (Tm) were identified by immunoblot. (B) The oxidation index is gi
Oxyblot and those of the corresponding bands stained with EZBlue. *p  0.00002
NF Donor and Severe Chronic HF Patient GroupTable 1 NF Donor and Severe Chronic HF Pa
NF
Age (yrs) 54.4 15
Sex (female/male) 11/25
Weight (kg) 75.4 5.0
Height (cm) 172 4.4
LVEF (%) 64.2 12.9
Left atrium diameter (mm) 35 6.7
LV end-diastolic diameter (mm) 46 5.8
LV systolic diameter (mm) 33 4.7
Heart rate (beats/min) 70 4.9
Systolic pressure (mm Hg) 118 6.8
Diastolic pressure (mm Hg) 65 5.7
TnI (g/l) 1.3 2.1
Ischemic time (min) 180 52
Diabetes mellitus 1/25
Hypertension 3/25
Smoker 4/25
NF donors died of subarachnoid hemorrhage–related brain death and
cardiac explantation (mean  SD). *p  0.0001 vs. NF.DCM dilated cardiomyopathy; HF heart failure; ICM ischemic cardiom
NF  nonfailing; TnI  troponin I.ng the immunoblots obtained after SDS-PAGE carried out
nder reducing and nonreducing conditions. The appearance
f these bands reflected DCB formation because they were
isible only in nonreducing electrophoresis.
Densitometric analysis (Fig. 3B) shows that the amount
f DCB in Tm was significantly increased in the HF group
 28) and nonfailing (NF; n  20) groups were subjected to dinitrophenyl (DNP)
ith anti-DNP antibodies. EZBlue staining was performed for protein loading. Actin
the ratio between the densitometric values of the actin and Tm bands in the
F vs. HF group. MW  molecular weight.
ilsGroup Details
HF
All HF DCM ICM
49.5 14 44.4 15.3 55 12
5/46 4/25 1/21
76.2 3.8 75.6 3.7 75.7 4.0
170 4.3 170 5.1 169 3.5
24.2 8.7* 24.2 8.3 23.2 9.1
48 4.9* 48 7.2 48 4.6
68 6.6* 69 7.2 67 6.0
63 8.1* 60 8.3 59 6.0
83 6.2* 81 5.6 79.7 5.1
125 6.1 118 6.8 125 5.5
76 5.0* 74 4.5 75 4.9
4.2 2.3* 4.1 1.6 4.5 2.6
139 73 140 93 135 46
0 0 0
16/46 0 16
1/46 0 1
e of overt cardiovascular disease. Plasma TnI was measured prior to(HF; n
bed w
ven by
for NDetatient
were freyopathy; LV left ventricular; LVEF left ventricular ejection fraction;
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Tropomyosin and Actin Oxidation in Heart Failure January 18, 2011:300–91.12  0.5 vs. 0.63  0.2 in the NF group; p  0.001).
nterestingly, Tm appeared especially susceptible to oxida-
ion because we could not detect DCB in actin and desmin
Fig. 4), although these proteins undergo oxidation both in
itro and in experimental models (11). Similarly, troponin
, cTnI, and myosin light chain did not show DCB
ormation.
We then analyzed the relationship between Tm oxidation
nd cTnI released prior to explantation. Plasma cTnI levels
nd LVEF correlated with the extent of DCB formation in
m when all of the samples were analyzed (y  0.0743x 
.6875, r2  0.18, p  0.003 and y  0.0107x  1.3364,
2  0.20, p  0.0002, respectively). However, when the
ithin-group correlation was considered, DCB formation
n the HF group was not significantly correlated with cTnI
Fig. 3C) (NF y  0.0214x  0.5768, r2  0.03, p  0.53;
F y 0.0214x 1, r2 0.01, p 0.657) nor with LVEF
NF y  0.0172x  0.5196, r2  0.31, p  0.01; HF y 
0.0087x  1.28724, r2  0.015, p  0.52).
Considering the large body of evidence related to the
nvolvement of nitric oxide in HF, we investigated whether
m is also a target of reactive nitrogen species. Because no
nformation was available on nitric oxide–induced changes in
Ps, initially we analyzed the occurrence of S-nitrosylation
i.e., the covalent attachment of nitric oxide to cysteine thiol)
Figure 2 Tm and Actin Carbonylation Correlates With Contract
The degree of Tm and actin oxidation significantly correlates with (A) left ventricul
(B) plasma cardiac troponin I (cTnI). Abbreviations as in Figure 1.y incubating Tm purified from rat myocardium with increas- Hng concentrations of S-nitrosoglutathione, a donor of nitric
xide. The purity of the protein was checked by reverse-phase
PLC, and the identity was confirmed by mass spectrometry
Fig. 5A). A mass of 32722.28  0.12 Da was measured,
hich matches the theoretic value. Figure 5B shows that
solated Tm undergoes S-nitrosylation.
Based upon this in vitro evidence, the occurrence and
xtent of MP S-nitrosylation were assessed in biopsies from
he HF and NF groups. Figure 6A shows that several MPs
nderwent S-nitrosylation. Most of these proteins were
imilarly S-nitrosylated in NF and HF samples. The major
xception was a band at 37 kDa, which corresponded to
m, as shown by immunoblot analysis (Fig. 6A). To
rovide additional evidence of the identity of the band
orresponding to Tm, samples from the NF and HF groups
ere immunoprecipitated after biotinylation with anti-Tm
ntibodies (Fig. 6B). The upper panel of Figure 6B shows
ncreased biotinylation/S-nitrosylation of Tm in HF sam-
les. The densitometric analysis of the Tm band in anti-
iotin immunoblots, normalized to the corresponding
ands in the Ponceau red–stained blots, displayed a
ignificant increase in the HF group (Fig. 6C) (154 
7.4 AU vs. 100  28.2 AU in the NF group; p  0.01).
his finding provides the first evidence of S-nitrosylation
f a specific MP, namely Tm, in human failing hearts.
sfunction and Loss of Myocardial Viability
tion fraction (LVEF) andile Dy
ar ejecowever, Tm nitrosylation did not correlate with cTnI
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January 18, 2011:300–9 Tropomyosin and Actin Oxidation in Heart Failurer LVEF (R2  0.1006, p  0.028 and R2  0.0901,
 0.038, respectively).
iscussion
he present results demonstrate a significant increase in
xidative modifications of MPs in end-stage human HF
ompared with NF donor hearts. In particular, we found
hat actin and Tm are carbonylated and Tm undergoes
CB formation as well as S-nitrosylation. In addition,
his study for the first time to our knowledge related MP
xidation with both contractile impairment and loss of
yocardial viability. This study was not only aimed at
roviding qualitative modifications of covalent changes,
ut also at establishing a quantitative correlation between
iochemical changes and functional alterations not pre-
iously investigated in clinical settings. Therefore, the
resent findings extend to human HF the correlation
etween MP oxidation and contractile impairment that
as previously demonstrated in an experimental model of
oronary microembolization (12).
P oxidation and cardiomyocyte dysfunction. Actin is
nown to be especially susceptible to carbonylation. This
Figure 3 Tm Oxidation in Human Left Ventricles Correlates Wit
(A) Myofibrillar proteins extracted from left ventricular biopsies of patients with HF
tions) or presence (reducing conditions) of -mercaptoethanol (-ME) and then ana
under nonreducing conditions. Equal loading was checked by Ponceau red (RP) sta
as DCB/native band (NB). Values are mean  SD. *p 0.0000376 for the NF vs.
and (Right) LVEF. Although plasma cTnI levels and LVEF correlated with the exten
differ significantly for within-group analysis of HF. Open diamonds  NF; solid circodification has been shown to occur in isolated rat hearts mubjected to post-ischemic reperfusion (11). Notably, car-
onylation has been demonstrated to result in progressive
isruption of actin filaments in vitro (17). Therefore, it is
ikely that actin oxidation affects contractile performance.
his concept is strongly supported by the present findings.
n fact, the significant increase in actin carbonyl content
etected in HF hearts was significantly correlated with both
ontractile derangement and loss of viability. Actin carbony-
ation appears to reflect reliably the oxidative degradation of
Ps. Our study also detected a similar alteration in Tm.
ropomyosin carbonylation correlated with both the de-
rease in LVEF and increase in plasma cTnI. The increase
f plasma cTnI levels has been documented in several
ardiovascular diseases, such as acute coronary syndromes,
cute decompensated heart failure (18), and chronic HF
19). Indeed, increased circulating cTnI levels are associated
ith poor clinical outcome in patients with cardiomyopathy
20) and are inversely correlated with LVEF in patients with
eptic shock (21). These relationships might explain the
educed calcium responsiveness of myofilaments that has
een proposed to underlie HF (22).
Although elevation of serum cTnI is a well-validated
s of Myocardial Viability
33) and NF (n  15) donors were denatured in the absence (nonreducing condi-
by anti-Tm immunoblot. Two additional bands were detected in HF samples
(B) The amount of disulfide cross-bridge (DCB) was quantified by densitometry
oup. (C) Relationship between Tm oxidation (DCB/NB) and (Left) plasma cTnI
B formation in Tm when the NF and HF groups were combined, these did not
HF. Abbreviations as in Figures 1 and 2.h Los
(n 
lyzed
ining.
HF gr
t of DC
les arker of necrotic myocyte injury during myocardial infarc-
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Tropomyosin and Actin Oxidation in Heart Failure January 18, 2011:300–9ion, the specific pathophysiology behind serum cTnI ele-
ation in HF is probably distinctly different than that caused
y acute ischemia (23). However, the chronic release of
TnI occurring in HF is still associated with progressive
orsening of ventricular pump function and poor clinical
utcome (20).
Carbonylation is likely to result from severe oxidative
tress. Under milder stress, proteins can be oxidatively
odified at the level of Cys residues (i.e., DCB formation).
ropomyosin oxidation was detected as the appearance of
igh-molecular-weight peptides in immunoelectrophoreses
erformed under nonreducing conditions. The band at 82
Da was attributed to a dimer of Tm (12), whereas the
ands with an apparent molecular mass200 kDa are likely
o reflect high-molecular-weight complexes among several
onomers of Tm or between Tm and other proteins. It is
orth pointing out that in rodents, cardiac Tm contains
nly the alpha isoform, whereas Tm from human cardiac
uscle contains up to 20% of the beta isoform. Different
han the alpha isoform by the presence of a single cysteine
Cys190), beta-Tm contains 2 Cys residues that might
esult in the covalent aggregation of more than 2 proteins by
eans of DCB formation.
The present results showed that DCB content in Tm was
Figure 4 No Evidence of DCB-Related MP Oxidation for Sarcom
Myofibrillar proteins (MPs) were extracted from left ventricular biopsies of the HF (
immunoblot probed with antibodies to specific sarcomeric MPs. No evidence of DC
ences were detected between these groups under nonreducing and reducing condignificantly higher in failing hearts. However, unlike car- oonylation, DCB formation correlated significantly with the
ecrease in LVEF and the increase in plasma cTnI only
hen the HF and NF groups were considered in combina-
ion (LVEF: r2  0.20, p  0.0002; cTnI: r2  0.17, p 
.003), whereas within-group regression analysis (i.e., con-
idering the HF and NF groups separately) did not result in
ignificant correlations. This might be because our study
nalyzed samples collected at end-stage failure, whereas
CB formation is likely to occur at an earlier stage. In fact,
n an acute experimental setting of HF, DCB formation
orrelated with contractile dysfunction (12).
We also considered nitrosative stress, which has been
emonstrated to occur in failing hearts (1,24). Indeed, we
ound that, besides DCB formation, Tm underwent
-nitrosylation. Because no information was available on
itrosative modifications of MPs, initially we investigated
he occurrence of S-nitrosylation in purified Tm upon
ncubation with S-nitrosoglutathione, a nitric oxide donor.
his finding might have been anticipated by analyzing the
rimary structure of Tm. Indeed, Cys190 in Tm is flanked
y an “acid-base motif” that is crucial for the occurrence of
-nitrosylation. This process is further favored by local pH,
edox tone, or presence of magnesium or calcium, which can
ll function as allosteric effectors to control thiol accessibility
Actin, Desmin, TnI, Troponin C and MLC
) and NF (n  8) groups, denatured as reported in Figure 3, and analyzed by
ation was obtained in the HF compared with NF group because no major differ-
MLC  myosin light chain; other abbreviations as in Figures 1, 2, and 3.eric
n  12
B form
itions.r reactivity (25).
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January 18, 2011:300–9 Tropomyosin and Actin Oxidation in Heart FailureAfter obtaining the first evidence of S-nitrosylation in
m, we analyzed its occurrence in human hearts. Interest-
ngly, S-nitrosylation of Tm was significantly greater in the
F than in the NF group. Nitric oxide synthase–dependent
nd nitric oxide synthase–independent (26) nitric oxide
ormation has been reported to contribute to contractile
ysfunction induced by chronic ischemia, eventually result-
ng in myocardial hibernation (27,28). Although the under-
ying mechanisms have not yet been elucidated, it may be
ypothesized that a contribution to these contractile de-
angements may arise from MP nitrosylation, along with
OS-induced covalent changes and nitrosylative modifica-
ions of proteins involved in Ca2 homeostasis (29).
tudy limitations. Our study cannot exclude oxidation or
ther post-translational modifications, such as (de)phos-
horylation and proteolysis, of different MPs that may be
ritical for the development of contractile impairment.
hese latter changes, far from being mutually exclusive with
OS-induced alterations, can be favored by oxidation, or in
Figure 5 Tm Is S-Nitrosylated In Vitro by S-Nitrosoglutathione
(A) Tropomyosin (Tm) purified by high-pressure liquid chromatography from rat
myocardium was incubated with S-nitrosoglutathione. (B) As detailed in the
Methods section, following the biotin-switch assay, the biotinylated/S-nitrosy-
lated Tm was precipitated with avidin-agarose beads and the pellet was
detected by anti-Tm immunoblot.urn, make proteins more susceptible to ROS. Although weid not detect any proteolysis of Tm, actin, and desmin, we
annot rule out that other MPs are proteolyzed. The
hosphorylation status of the MPs is important in several
odels of HF (30). Notably, p38 mitogen-activated protein
inase (p38MAPK) activation is associated with Tm de-
hosphorylation and reduced sarcomeric function (31).
lthough we did not assess MP phosphorylation, the
ctivation of p38MAPK favors ROS formation so that any
Figure 6 Detection of S-Nitrosylated Proteins in
Human Left Ventricles
(A) MPs were extracted from left ventricular biopsies of the HF (n  36) and NF (n 
24) groups and subjected to the biotin-switch assay. (B) To ascertain the identity of
the band corresponding to Tm in the anti-biotin blot of A, the derived biotinylated pro-
teins were immunoprecipitated with an anti-Tm monoclonal antibody. Immunoblots of
the pellets were stained with anti-Tm, to confirm the immunoprecipitation, and anti-
biotin antibodies. (C) The density of the band in the HF group was markedly increased
in the immunoblot probed with the anti-biotin antibody, indicating major S-nitrosylation
(SNO) in this group. Equal loading was checked by RP staining. The amount of
S-nitrosylated Tm was given by the ratio between the densitometric values of the
S-nitrosylated bands and those of the corresponding bands stained with RP. Values
are mean  SD. *p  0.05 for the NF versus HF group.
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Tropomyosin and Actin Oxidation in Heart Failure January 18, 2011:300–9unctional changes resulting from Tm dephosphorylation
ould have been secondary to oxidation or vice versa.
Apart from the general limitation of subject numbers in
ach group and varying life histories, another limitation
nvolved the availability of “control” human myocardium
nd sample handling. Donor hearts were obtained following
rain death and were subject to the Cushing reflex that may
nvolve acute pacing/ischemia-reperfusion stress on the
yocardium, which may have contributed to oxidative
odification of MPs. This effect on the heart varies in time
nd severity among donors and cannot be directly controlled
n the clinical setting. Although ischemic time (owing to
ardioplegic ischemic arrest and storage) can contribute to
xidative modifications of MPs, this was not significantly
ifferent between the NF and HF groups (Table 1). Thus,
pon sample collection, both failing and NF hearts were
xposed to oxidative stress, but this “oxidative background”
as probably higher in donors because of the Cushing reflex
hat is precipitated during brain death. It is likely that,
ithout this background, differences between the NF and
F groups would be greater.
Finally, although the present correlations between MP
xidation and contractile dysfunction appear to confirm
vidence similar to that obtained in experimental models, far
rom emphasizing these interesting findings, we would like
o point out that inevitably cardiac function was measured at
imes different than sample collection. Although it is not
ikely that major variations in oxidative stress occurred in the
arrow time intervals during end-stage HF, our data cor-
elated parameters measured at different times.
onclusions
he present results demonstrated that human HF, with
evere contractile dysfunction as evidenced by poor LVEF
hat limits cardiac output, involves metabolic stresses that
nduce specific oxidative and nitrosative covalent changes of
ctin and Tm, thus impeding their molecular function. On
he basis of the localization and crucial role of actin and Tm
n myofilaments, these molecular changes in the MPs are
ighly predictive of marked interference with myofibrillar
ontractile performance. Although changes in gene expres-
ion of MPs (i.e., titin, myosin heavy chain) may impact
ontractile function in HF, the specific oxidative modifica-
ions of MPs identified in this study may serve as crucial
herapeutic targets because they are likely to occur at earlier
tages.
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